ArticleCureus2025
The Clinical Significance of the Magee Equations in Breast Cancer Prognostication.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tumour-infiltrating lymphocytes differ across MammaPrint® classifications in breast cancer.Endocrine-related cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The landscape of breast cancer management has been revolutionized by advancements in molecular diagnostics, yet accessibility and cost remain significant barriers for many patients. Limited-resource settings often face significant challenges in accessing expensive molecular tests, which can impact timely diagnosis and treatment decisions. The Magee equations present a practical, cost-effective solution that can bridge this gap, ensuring that patients, regardless of their financial or geographic limitations, receive appropriate and timely treatment. Originally developed at the University of Pittsburgh Medical Center, these equations offer a reliable alternative for estimating recurrence scores without the prohibitive costs associated with genomic assays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.